Article info

Original research
Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab

Authors

  1. Correspondence to Dr Steffen Pfeuffer, Neurology, Universitatsklinikum Munster, Münster D-48145, Germany; steffen.pfeuffer{at}ukmuenster.de
View Full Text

Citation

Pfeuffer S, Ruck T, Pul R, et al
Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab

Publication history

  • Received October 3, 2020
  • Revised January 14, 2021
  • Accepted February 7, 2021
  • First published March 12, 2021.
Online issue publication 
August 13, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.